MCF (mitomycin, cisplatin, 5-fluorouracil)

Adjuvant and palliative treatment of gastric and oesophageal cancers, especially in patients who are unsuitable for anthracycline treatment, or who have previously been treated with ECF and are therefore unsuitable for MCF.